Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function

Grazia Chiellini, Sabina Frascarelli, Sandra Ghelardoni, Vittoria Carnicelli, Sandra C. Tobias, Andrea De Barber, Simona Brogioni, Simonetta Ronca-Testoni, Elisabetta Cerbai, David Grandy, Thomas (Tom) Scanlan, Riccardo Zucchi

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

3-iodothyronamine T1AM is a novel endogenous thyroid hormone derivative that activates the G protein-coupled receptor known as trace anime-associated receptor 1 (TAAR1). In the isolated working rat heart and in rat cardiomyocytes, T1AM produced a reversible, dose-dependent negative inotropic effect (e.g., 27±5, 51±3, and 65±2% decrease in cardiac output at 19, 25, and 38 μM concentration, respectively). An independent negative chronotropic effect was also observed. The hemodynamic effects of T1AM were remarkably increased in the presence of the tyrosine kinase inhibitor genistein, whereas they were attenuated in the presence of the tyrosine phosphatase inhibitor vanadate. No effect was produced by inhibitors of protein kinase A, protein kinase C, calciumcalmodulin kinase II, phosphatidylinositol-3-kinase, or MAP kinases. Tissue cAMP levels were unchanged. In rat ventricular tissue, Western blot experiments with antiphosphotyrosine antibodies showed reduced phosphorylation of microsomal and cytosolic proteins after perfusion with synthetic T1AM; reverse transcriptase-polymerase chain reaction experiments revealed the presence of transcripts for at least 5 TAAR subtypes; specific and saturable binding of [125I]T1AM was observed, with a dissociation constant in the low micromolar range (5 μM); and endogenous T1AM was detectable by tandem mass spectrometry. In conclusion, our findings provide evidence for the existence of a novel aminergic system modulating cardiac function.

Original languageEnglish (US)
Pages (from-to)1597-1608
Number of pages12
JournalFASEB Journal
Volume21
Issue number7
DOIs
StatePublished - May 2007

Fingerprint

cardiac output
Rats
tyrosine
rats
phosphotransferases (kinases)
Phosphatidylinositol 3-Kinase
Tissue
Phosphorylation
cAMP-dependent protein kinase
Vanadates
Genistein
Polymerase chain reaction
RNA-Directed DNA Polymerase
phosphatidylinositol 3-kinase
genistein
Hemodynamics
protein kinase C
hemodynamics
thyroid hormones
G-Protein-Coupled Receptors

Keywords

  • G protein-coupled receptors
  • Myocardial function
  • Signal transduction
  • Thyronamines

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Chiellini, G., Frascarelli, S., Ghelardoni, S., Carnicelli, V., Tobias, S. C., De Barber, A., ... Zucchi, R. (2007). Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function. FASEB Journal, 21(7), 1597-1608. https://doi.org/10.1096/fj.06-7474com

Cardiac effects of 3-iodothyronamine : A new aminergic system modulating cardiac function. / Chiellini, Grazia; Frascarelli, Sabina; Ghelardoni, Sandra; Carnicelli, Vittoria; Tobias, Sandra C.; De Barber, Andrea; Brogioni, Simona; Ronca-Testoni, Simonetta; Cerbai, Elisabetta; Grandy, David; Scanlan, Thomas (Tom); Zucchi, Riccardo.

In: FASEB Journal, Vol. 21, No. 7, 05.2007, p. 1597-1608.

Research output: Contribution to journalArticle

Chiellini, G, Frascarelli, S, Ghelardoni, S, Carnicelli, V, Tobias, SC, De Barber, A, Brogioni, S, Ronca-Testoni, S, Cerbai, E, Grandy, D, Scanlan, TT & Zucchi, R 2007, 'Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function', FASEB Journal, vol. 21, no. 7, pp. 1597-1608. https://doi.org/10.1096/fj.06-7474com
Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, De Barber A et al. Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function. FASEB Journal. 2007 May;21(7):1597-1608. https://doi.org/10.1096/fj.06-7474com
Chiellini, Grazia ; Frascarelli, Sabina ; Ghelardoni, Sandra ; Carnicelli, Vittoria ; Tobias, Sandra C. ; De Barber, Andrea ; Brogioni, Simona ; Ronca-Testoni, Simonetta ; Cerbai, Elisabetta ; Grandy, David ; Scanlan, Thomas (Tom) ; Zucchi, Riccardo. / Cardiac effects of 3-iodothyronamine : A new aminergic system modulating cardiac function. In: FASEB Journal. 2007 ; Vol. 21, No. 7. pp. 1597-1608.
@article{6f4d3cd5b147459f92a053b9af48e305,
title = "Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function",
abstract = "3-iodothyronamine T1AM is a novel endogenous thyroid hormone derivative that activates the G protein-coupled receptor known as trace anime-associated receptor 1 (TAAR1). In the isolated working rat heart and in rat cardiomyocytes, T1AM produced a reversible, dose-dependent negative inotropic effect (e.g., 27±5, 51±3, and 65±2{\%} decrease in cardiac output at 19, 25, and 38 μM concentration, respectively). An independent negative chronotropic effect was also observed. The hemodynamic effects of T1AM were remarkably increased in the presence of the tyrosine kinase inhibitor genistein, whereas they were attenuated in the presence of the tyrosine phosphatase inhibitor vanadate. No effect was produced by inhibitors of protein kinase A, protein kinase C, calciumcalmodulin kinase II, phosphatidylinositol-3-kinase, or MAP kinases. Tissue cAMP levels were unchanged. In rat ventricular tissue, Western blot experiments with antiphosphotyrosine antibodies showed reduced phosphorylation of microsomal and cytosolic proteins after perfusion with synthetic T1AM; reverse transcriptase-polymerase chain reaction experiments revealed the presence of transcripts for at least 5 TAAR subtypes; specific and saturable binding of [125I]T1AM was observed, with a dissociation constant in the low micromolar range (5 μM); and endogenous T1AM was detectable by tandem mass spectrometry. In conclusion, our findings provide evidence for the existence of a novel aminergic system modulating cardiac function.",
keywords = "G protein-coupled receptors, Myocardial function, Signal transduction, Thyronamines",
author = "Grazia Chiellini and Sabina Frascarelli and Sandra Ghelardoni and Vittoria Carnicelli and Tobias, {Sandra C.} and {De Barber}, Andrea and Simona Brogioni and Simonetta Ronca-Testoni and Elisabetta Cerbai and David Grandy and Scanlan, {Thomas (Tom)} and Riccardo Zucchi",
year = "2007",
month = "5",
doi = "10.1096/fj.06-7474com",
language = "English (US)",
volume = "21",
pages = "1597--1608",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "7",

}

TY - JOUR

T1 - Cardiac effects of 3-iodothyronamine

T2 - A new aminergic system modulating cardiac function

AU - Chiellini, Grazia

AU - Frascarelli, Sabina

AU - Ghelardoni, Sandra

AU - Carnicelli, Vittoria

AU - Tobias, Sandra C.

AU - De Barber, Andrea

AU - Brogioni, Simona

AU - Ronca-Testoni, Simonetta

AU - Cerbai, Elisabetta

AU - Grandy, David

AU - Scanlan, Thomas (Tom)

AU - Zucchi, Riccardo

PY - 2007/5

Y1 - 2007/5

N2 - 3-iodothyronamine T1AM is a novel endogenous thyroid hormone derivative that activates the G protein-coupled receptor known as trace anime-associated receptor 1 (TAAR1). In the isolated working rat heart and in rat cardiomyocytes, T1AM produced a reversible, dose-dependent negative inotropic effect (e.g., 27±5, 51±3, and 65±2% decrease in cardiac output at 19, 25, and 38 μM concentration, respectively). An independent negative chronotropic effect was also observed. The hemodynamic effects of T1AM were remarkably increased in the presence of the tyrosine kinase inhibitor genistein, whereas they were attenuated in the presence of the tyrosine phosphatase inhibitor vanadate. No effect was produced by inhibitors of protein kinase A, protein kinase C, calciumcalmodulin kinase II, phosphatidylinositol-3-kinase, or MAP kinases. Tissue cAMP levels were unchanged. In rat ventricular tissue, Western blot experiments with antiphosphotyrosine antibodies showed reduced phosphorylation of microsomal and cytosolic proteins after perfusion with synthetic T1AM; reverse transcriptase-polymerase chain reaction experiments revealed the presence of transcripts for at least 5 TAAR subtypes; specific and saturable binding of [125I]T1AM was observed, with a dissociation constant in the low micromolar range (5 μM); and endogenous T1AM was detectable by tandem mass spectrometry. In conclusion, our findings provide evidence for the existence of a novel aminergic system modulating cardiac function.

AB - 3-iodothyronamine T1AM is a novel endogenous thyroid hormone derivative that activates the G protein-coupled receptor known as trace anime-associated receptor 1 (TAAR1). In the isolated working rat heart and in rat cardiomyocytes, T1AM produced a reversible, dose-dependent negative inotropic effect (e.g., 27±5, 51±3, and 65±2% decrease in cardiac output at 19, 25, and 38 μM concentration, respectively). An independent negative chronotropic effect was also observed. The hemodynamic effects of T1AM were remarkably increased in the presence of the tyrosine kinase inhibitor genistein, whereas they were attenuated in the presence of the tyrosine phosphatase inhibitor vanadate. No effect was produced by inhibitors of protein kinase A, protein kinase C, calciumcalmodulin kinase II, phosphatidylinositol-3-kinase, or MAP kinases. Tissue cAMP levels were unchanged. In rat ventricular tissue, Western blot experiments with antiphosphotyrosine antibodies showed reduced phosphorylation of microsomal and cytosolic proteins after perfusion with synthetic T1AM; reverse transcriptase-polymerase chain reaction experiments revealed the presence of transcripts for at least 5 TAAR subtypes; specific and saturable binding of [125I]T1AM was observed, with a dissociation constant in the low micromolar range (5 μM); and endogenous T1AM was detectable by tandem mass spectrometry. In conclusion, our findings provide evidence for the existence of a novel aminergic system modulating cardiac function.

KW - G protein-coupled receptors

KW - Myocardial function

KW - Signal transduction

KW - Thyronamines

UR - http://www.scopus.com/inward/record.url?scp=34247564558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247564558&partnerID=8YFLogxK

U2 - 10.1096/fj.06-7474com

DO - 10.1096/fj.06-7474com

M3 - Article

C2 - 17284482

AN - SCOPUS:34247564558

VL - 21

SP - 1597

EP - 1608

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 7

ER -